Comparing the utility of FDG PET-CT and contrast-enhanced CT in patients with oesophagogastric adenocarcinoma treated with neoadjuvant chemotherapy - Poll - MDSpire
Coming Soon: Introducing MDSpire News. Learn more
Conexiant’s news site is now MDSpire News. Learn more

Evaluating the Effectiveness of FDG PET-CT Versus Contrast-Enhanced CT in Oesophagogastric Adenocarcinoma Patients Undergoing Neoadjuvant Chemotherapy

  • By

  • J. L. Moore

  • M. Arora

  • C. Sit

  • R. Rahman

  • M. Green

  • H. Deere

  • J. Lagergren

  • S. Chicklore

  • F. Chinaka

  • N. Maisey

  • S. Ngan

  • A. Sita-Lumsden

  • A. Qureshi

  • K. Owczarczyk

  • W. R. C. Knight

  • M. Kelly

  • C. R. Baker

  • J. A. Gossage

  • M. Subesinghe

  • A. R. Davies

  • September 17, 2026

Share

Original Source(s)

Related Content